Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-018464
Filing Date
2022-05-17
Accepted
2022-05-17 19:32:28
Documents
3
Period of Report
2022-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5783
2 EX-24 DOCUMENT attachment1.htm EX-24 3136
3 EX-24 DOCUMENT attachment2.htm EX-24 1701
  Complete submission text file 0000899243-22-018464.txt   12129
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 22936542